Dynamic changes of Th1/Th2/Th17 cytokines and human beta defensin 2 in HIV-infected patients with oral candidiasis during the first year of highly active anti-retroviral therapy
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Archives of Oral Biology
- Vol. 92, 62-67
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81060085, 81260167, 81060085, 81260167)
This publication has 28 references indexed in Scilit:
- Evaluation of saliva collection devices for the analysis of proteinsClinica Chimica Acta, 2012
- Th17 Cells in Immunity to Candida albicansCell Host & Microbe, 2012
- Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 ImmunityScience, 2011
- Immunity to fungal infectionsNature Reviews Immunology, 2011
- Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasisJournal of Experimental Medicine, 2009
- Farnesol promotes epithelial cell defense against Candida albicans through Toll-like receptor 2 expression, interleukin-6 and human β-defensin 2 productionCytokine, 2009
- Targeting the development and effector functions of TH17 cellsSeminars in Immunology, 2007
- Host factors and the pathogenesis of HIV-induced diseaseNature, 1996
- Classification and diagnostic criteria for oral lesions in HIV infectionJournal of Oral Pathology & Medicine, 1993
- A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavityJournal of Oral Pathology & Medicine, 1986